185 related articles for article (PubMed ID: 37957606)
1. Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis.
Stoecklein NH; Fluegen G; Guglielmi R; Neves RPL; Hackert T; Birgin E; Cieslik SA; Sudarsanam M; Driemel C; van Dalum G; Franken A; Niederacher D; Neubauer H; Fehm T; Rox JM; Böhme P; Häberle L; Göring W; Esposito I; Topp SA; Coumans FAW; Weitz J; Knoefel WT; Fischer JC; Bork U; Rahbari NN
Mol Cancer; 2023 Nov; 22(1):181. PubMed ID: 37957606
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting.
Fehm TN; Meier-Stiegen F; Driemel C; Jäger B; Reinhardt F; Naskou J; Franken A; Neubauer H; Neves RPL; van Dalum G; Ruckhäberle E; Niederacher D; Rox JM; Fischer JC; Stoecklein NH
Cytometry A; 2018 Dec; 93(12):1213-1219. PubMed ID: 30551262
[TBL] [Abstract][Full Text] [Related]
3. Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival.
Tamminga M; Andree KC; van den Bos H; Hiltermann TJN; Mentink A; Spierings DCJ; Lansdorp P; Timens W; Schuuring E; Terstappen LWMM; Groen HJM
Br J Cancer; 2022 Feb; 126(3):409-418. PubMed ID: 34848855
[TBL] [Abstract][Full Text] [Related]
4. Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap).
Andree KC; Mentink A; Zeune LL; Terstappen LWMM; Stoecklein NH; Neves RP; Driemel C; Lampignano R; Yang L; Neubauer H; Fehm T; Fischer JC; Rossi E; Manicone M; Basso U; Marson P; Zamarchi R; Loriot Y; Lapierre V; Faugeroux V; Oulhen M; Farace F; Fowler G; Sousa Fontes M; Ebbs B; Lambros M; Crespo M; Flohr P; de Bono JS
Int J Cancer; 2018 Nov; 143(10):2584-2591. PubMed ID: 30006930
[TBL] [Abstract][Full Text] [Related]
5. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
[TBL] [Abstract][Full Text] [Related]
6. Technical validation of a new microfluidic device for enrichment of CTCs from large volumes of blood by using buffy coats to mimic diagnostic leukapheresis products.
Guglielmi R; Lai Z; Raba K; van Dalum G; Wu J; Behrens B; Bhagat AAS; Knoefel WT; Neves RPL; Stoecklein NH
Sci Rep; 2020 Nov; 10(1):20312. PubMed ID: 33219265
[TBL] [Abstract][Full Text] [Related]
7. Improved enrichment of circulating tumor cells from diagnostic leukapheresis product.
Stevens M; Mentink A; Nanou A; Coumans FAW; Isebia KT; Kraan J; Hamberg P; Martens JWM; Terstappen LWMM
Cytometry A; 2023 Nov; 103(11):881-888. PubMed ID: 37461156
[TBL] [Abstract][Full Text] [Related]
8. Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch
Tamminga M; Andree KC; Hiltermann TJN; Jayat M; Schuuring E; van den Bos H; Spierings DCJ; Lansdorp PM; Timens W; Terstappen LWMM; Groen HJM
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32272669
[TBL] [Abstract][Full Text] [Related]
9. Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products.
Franken A; Driemel C; Behrens B; Meier-Stiegen F; Endris V; Stenzinger A; Niederacher D; Fischer JC; Stoecklein NH; Ruckhaeberle E; Fehm T; Neubauer H
Clin Chem; 2019 Apr; 65(4):549-558. PubMed ID: 30737205
[TBL] [Abstract][Full Text] [Related]
10. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
11. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells.
Rieckmann LM; Spohn M; Ruff L; Agorku D; Becker L; Borchers A; Krause J; O'Reilly R; Hille J; Velthaus-Rusik JL; Beumer N; Günther A; Willnow L; Imbusch CD; Iglauer P; Simon R; Franzenburg S; Winter H; Thomas M; Bokemeyer C; Gagliani N; Krebs CF; Sprick M; Hardt O; Riethdorf S; Trumpp A; Stoecklein NH; Peine S; Rosenstiel P; Pantel K; Loges S; Janning M
Mol Cancer; 2024 May; 23(1):93. PubMed ID: 38720314
[TBL] [Abstract][Full Text] [Related]
13. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.
Stoecklein NH; Fischer JC; Niederacher D; Terstappen LW
Expert Rev Mol Diagn; 2016; 16(2):147-64. PubMed ID: 26587751
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.
Fischer JC; Niederacher D; Topp SA; Honisch E; Schumacher S; Schmitz N; Zacarias Föhrding L; Vay C; Hoffmann I; Kasprowicz NS; Hepp PG; Mohrmann S; Nitz U; Stresemann A; Krahn T; Henze T; Griebsch E; Raba K; Rox JM; Wenzel F; Sproll C; Janni W; Fehm T; Klein CA; Knoefel WT; Stoecklein NH
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16580-5. PubMed ID: 24065821
[TBL] [Abstract][Full Text] [Related]
15. Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma.
White MG; Lee A; Vicente D; Hall C; Kim MP; Katz MHG; Lee JE; Ikoma N; Lucci A; Tzeng CD
Ann Surg Oncol; 2021 Aug; 28(8):4615-4622. PubMed ID: 33415562
[TBL] [Abstract][Full Text] [Related]
16. Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients.
Tamminga M; Oomens L; Hiltermann TJN; Andree KC; Tibbe A; Broekmaat J; Schuuring E; Terstappen LWMM; Groen HJM
Transl Lung Cancer Res; 2020 Aug; 9(4):1093-1100. PubMed ID: 32953488
[TBL] [Abstract][Full Text] [Related]
17. High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery.
Buscail E; Alix-Panabières C; Quincy P; Cauvin T; Chauvet A; Degrandi O; Caumont C; Verdon S; Lamrissi I; Moranvillier I; Buscail C; Marty M; Laurent C; Vendrely V; Moreau-Gaudry F; Bedel A; Dabernat S; Chiche L
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31717747
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single-center study.
Dizdar L; Fluegen G; van Dalum G; Honisch E; Neves RP; Niederacher D; Neubauer H; Fehm T; Rehders A; Krieg A; Knoefel WT; Stoecklein NH
Mol Oncol; 2019 Jul; 13(7):1548-1558. PubMed ID: 31116510
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery.
Sergeant G; van Eijsden R; Roskams T; Van Duppen V; Topal B
BMC Cancer; 2012 Nov; 12():527. PubMed ID: 23157946
[TBL] [Abstract][Full Text] [Related]
20. A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer.
Chen J; Wang H; Zhou L; Liu Z; Tan X
J Clin Lab Anal; 2022 May; 36(5):e24341. PubMed ID: 35334495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
